Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population

AIM: Cerebrovascular disease is the leading cause of death and disability in China, causing a huge burden among patients and their families. Hence, stroke prevention is critical, especially in the high-risk population. Here, we present the evidence-based guideline suitable for the Chinese population...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yilong, Han, Shangrong, Qin, Haiqiang, Zheng, Huaguang, Jiang, Bin, Cao, Yong, Gao, Yuan, Guan, Ling, Jia, Qian, Jiang, Yong, Jiao, Yuming, Li, Shuya, Li, Yapeng, Li, Zixiao, Liu, Wei, Ru, Xiaojuan, Sun, Dongling, Sun, Haixin, Wang, Penglian, Wang, Tingting, Zong, Lixia, Guo, Lei, Xie, Xuewei, Xu, Yuming, Xu, Yuyuan, Yang, Xiaomeng, Yang, Yingying, Zhou, Mengyuan, Wang, Wenzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548516/
https://www.ncbi.nlm.nih.gov/pubmed/32792457
http://dx.doi.org/10.1136/svn-2020-000385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548516/
https://www.ncbi.nlm.nih.gov/pubmed/32792457
http://dx.doi.org/10.1136/svn-2020-000385

Ejemplares similares